Literature DB >> 17133571

Liver transplantation for fulminant hepatitis related to nevirapine therapy.

Sophie Buyse1, Eric Vibert, Mylène Sebagh, Teresa Antonini, Philippe Ichai, Denis Castaing, Didier Samuel, Jean-Charles Duclos-Vallée.   

Abstract

Drug-induced hepatotoxicity is an important cause of hepatocellular injury. Non-nucleoside retroviral transcriptase inhibitors are known to cause hepatotoxicity. We describe a detailed case of fulminant hepatitis induced by nevirapine (Viramune) and treated by liver transplantation.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17133571     DOI： 10.1002/lt.20985

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


  4 in total

1.  Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing Regimens.

Authors:  Debika Bhattacharya; Amita Gupta; Camlin Tierney; Sharon Huang; Marion G Peters; Tsungai Chipato; Frances Martinson; Neaka Mohtashemi; Dingase Dula; Kathy George; Nahida Chaktoura; Karin L Klingman; Devasena Gnanashanmugam; Judith S Currier; Mary G Fowler
Journal:  Clin Infect Dis       Date:  2021-04-26       Impact factor: 9.079

Review 2.  Practical guidelines for diagnosis and early management of drug-induced liver injury.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

3.  Quantifying the metabolic activation of nevirapine in patients by integrated applications of NMR and mass spectrometries.

Authors:  Abhishek Srivastava; Lu-Yun Lian; James L Maggs; Masautso Chaponda; Munir Pirmohamed; Dominic P Williams; B Kevin Park
Journal:  Drug Metab Dispos       Date:  2010-01       Impact factor: 3.922

4.  Twelfth-Position Deuteration of Nevirapine Reduces 12-Hydroxy-Nevirapine Formation and Nevirapine-Induced Hepatocyte Death.

Authors:  Carley J S Heck; Herana Kamal Seneviratne; Namandjé N Bumpus
Journal:  J Med Chem       Date:  2020-02-27       Impact factor: 7.446
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.